Rigel Pharmaceuticals Inc
RIGLNasdaqCIK 1034842HealthcareFiscal year ends Dec 31
Reports and events: 282 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0716:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-017987 |
| 2023-08-0116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-086368 |
| 2023-08-0116:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-012722 |
| 2023-05-3016:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-23-065988 |
| 2023-05-0216:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-055028 |
| 2023-05-0216:06 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-007653 |
| 2023-04-1408:03 ET | DEF 14A | Proxy statement | 0001140361-23-018393 |
| 2023-03-0716:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-029558 |
| 2023-03-0716:05 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-003035 |
| 2023-02-0316:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-010536 |
| 2023-01-0908:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-002074 |
| 2022-12-0206:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-123853 |
| 2022-11-2916:05 ET | 8-K | 3.01 Delisting notice | 0001104659-22-122864 |
| 2022-11-0316:25 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-016266 |
| 2022-11-0316:05 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-22-114413 |
| 2022-11-0116:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-113463 |
| 2022-10-1116:15 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-107725 |
| 2022-08-0216:11 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-22-085188 |
| 2022-08-0216:07 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-011638 |
| 2022-07-2517:12 ET | 8-K | 8.01 Other events | 0001104659-22-082470 |
| 2022-06-2316:15 ET | 8-K | 8.01 Other events | 0001104659-22-073906 |
| 2022-06-0816:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-069317 |
| 2022-05-2316:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-22-063899 |
| 2022-05-0316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-055272 |
| 2022-05-0316:08 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-006809 |
| 2022-04-0516:35 ET | DEF 14A | Proxy statementPeriod 2022-05-19 | 0001140361-22-013177 |
| 2022-03-0116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-028673 |
| 2022-03-0116:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-002551 |
| 2022-02-1716:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-22-024757 |
| 2022-01-2816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-008984 |
| 2022-01-1008:40 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-002534 |
| 2021-12-1716:40 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-151192 |
| 2021-11-1509:00 ET | 8-K | 2.05 Exit or disposal costs | 0001104659-21-138665 |
| 2021-11-0216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-132987 |
| 2021-11-0216:02 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-014076 |
| 2021-08-1316:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-105111 |
| 2021-08-0316:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-099471 |
| 2021-08-0316:03 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-009976 |
| 2021-05-2116:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-21-070459 |
| 2021-05-1409:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-066458 |
| 2021-05-0516:02 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001558370-21-005903 |
| 2021-05-0516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-061696 |
| 2021-04-1317:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-049830 |
| 2021-04-0617:28 ET | DEF 14A | Proxy statementPeriod 2021-05-18 | 0001104659-21-047180 |
| 2021-03-0216:05 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001558370-21-002254 |
| 2021-03-0216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-030711 |
| 2021-02-1806:30 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-21-025010 |
| 2021-02-0316:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-21-011506 |
| 2021-01-1116:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-002993 |
| 2020-11-0516:05 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001558370-20-012838 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:09 ET. Listed shows no prices and gives no investment advice.